Aptevo Therapeutics (AP81.F) Q2 2026 Earnings

Apr 1Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-78.46
-52.43
-26.41
-0.38

Details

Expected EPS
-0.38213100000000005
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Aptevo Therapeutics⁩ (⁦AP81.F⁩) will report earnings of for ⁦Q2 2026⁩ on April 1, 2026.

0 Comments

Share your thoughts